Products & Alliances
PrEP Biopharm Ltd
hVIVO Innovation Areas
Challenge Study Services
Target & Biomarker Discovery
Aim Rule 26
Press and Media Contact
experimental influenza virus challenge
human monoclonal antibody
hVIVO challenge model
influenza disease model
TCN-032; anti-M2e antibody; influenza viral challenge. influenza rsearch
Scientific Papers: influenza
Scientific Paper 75 : Influenza is now a preventable disease
Scientific Paper 63 : Treatment of epidemic and pandemic influenza with neuraminidase and M2 proton channel inhibitors.
Scientific Paper 62 : Non-responders to egg grown influenza vaccine seroconvert after booster immunization with MDCK cell grown vaccine.
Scientific paper 68 – A new millennium conundrum: how to use a powerful class of influenza anti-neuraminidase drugs (NAIs) in the community.
Scientific Paper 84 : A plant-produced influenza subunit vaccine protects ferrets against virus challenge.
Scientific Paper 73 : Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection.
Scientific Paper 65 : Strong local and systemic protective immunity induced in the ferret model by an intranasal virosome-formulated influenza subunit vaccine.
Scientific Paper 50 : Rapid antibody response to influenza vaccination in “at risk” groups.
Scientific Paper 66 : Human genetics and responses to influenza vaccination: clinical implications.
Scientific Paper 23 : Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.